Corrigendum to “Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin” [Biomed. Pharmacother. 173 (2024) 116360] - 25/03/26
Doi : 10.1016/j.biopha.2026.119213
Zhenzhen Deng a, b, d, Suo Qishan a, b, d, Quanbin Zhang a, b, d, Jing Wang a, b, Yang Yue a, b, Lihua Geng a, b, Ning Wu a, c, d, ⁎ 
a CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China
b Lab for Marine Biology and Biotechnology, Qingdao National Lab for Marine Sci. & Tech, Qingdao 266071, China
c Laboratory for Marine Drugs And Biological Products, Pilot National Laboratory for Marine Science and Technology (Qingdao), China
d University of Chinese Academy of Sciences, Beijing 100049, China
⁎ Corresponding author at: CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China. CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences Qingdao 266071 China
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 197
Article 119213- avril 2026 Retour au numéro
Article précédent
- Corrigendum to “Methyleugenol alleviates pulmonary vascular remodeling in rats with high-altitude pulmonary hypertension by improving pulmonary smooth muscle cell function” [Biomed. Pharmacother. 187 (2025) 118109]
- Yang Yu, Yurong Wang, Ziqi Yang, Zhanqiang Li, Dianxiang Lu, Xingmei Nan
- Retraction notice to “Volatile anesthetics sevoflurane targets leukemia stem/progenitor cells via Wnt/β-catenin inhibition” [Biomed. Pharmacother. 107 (2018), 1294–1301]
- Xuguang Ruan, Weihang Jiang, Pingrui Cheng, Lingyan Huang, Xuelan Li, Yingyi He, Minyi Mai, Zhimin Tan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?